
Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker

The Latest

Dinty Moore Beef Stew
Where’s the beef?

CATrends: QLED TVs
Lawsuits allege quantum technology claims aren’t picture-perfect.

Steve Madden: Shoe Shrink
Who needs therapy when you have shoes?

FitOn’s Never-Ending Sale
If it’s always a sale, it’s never a sale.

It’s 10 p.m. Do You Know Where on Roblox Your Children Are?
Sam Biddle, New York Magazine – Intelligencer